Results 161 to 170 of about 89,710 (188)

Effect of exposure on the chemical composition and in vitro dry matter digestibility of untreated and formalin treated green chop

Animal Feed Science and Technology, 1993
Green chop, made from babala (Pennisetum typhoides) and forage sorghum (Sorghum bicolor sudanense) which were each harvested from six different rows at the pre-bloom and bloom stages of maturity, were exposed to the environment with and without formalin treatment (4.9 ± 0.8 g formaldehyde per 100 g crude protein) for a period of 21 ± 3 h. This was done
openaire   +1 more source

Biuret and Urea in Supplements for Bovines Fed Green Chop Elephant Grass

Journal of Animal Science, 1971
C F, Chicco, T A, Shultz, A A, Carnevali, L, Oropeza, C B, Ammerman   +4 more
openaire   +2 more sources

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL

Cancer Cell, 2021
George W Wright, Louis M Staudt
exaly  

The potential of different forage combinations for green-chop silage

2005
T.L. Knight, T.J. Fraser, T.A. White, M.G. Hyslop   +3 more
openaire   +1 more source

1426 Effects of feeding green chopped winter forages on digestibility, ruminal fermentation and blood parameters in beef steers

Journal of Animal Science, 2016
T. M. Schulmeister, M. Ruiz-Moreno, M. E. Garcia-Ascolani, F. M. Ciriaco, D. D. Henry, J. Benitez, J. C. B. Dubeux, G. C. Lamb, N. DiLorenzo   +8 more
openaire   +1 more source

Effects of energy supplementation on energy losses and nitrogen balance of steers fed green-chopped wheat pasture I: Calorimetry123

Journal of Animal Science, 2017
A. L. Shreck, P. J. Ebert, E. A. Bailey, J. S. Jennings, K. D. Casey, B. E. Meyer, N. A. Cole   +6 more
openaire   +1 more source

Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma

Ca-A Cancer Journal for Clinicians, 2010
Christopher R Flowers
exaly  

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

New England Journal of Medicine, 2002
Bertrand Coiffier, Raoul Herbrecht, Philippe Gaulard   +2 more
exaly  

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Lancet, The, 2013
Dieter Hoelzer
exaly  

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Lancet, The, 2019
Mathias Witzens-Harig, Harald Holte, Peter Borchmann   +2 more
exaly